when will wegovy be on pbs in australia

Wegovy is not on the PBS in Australia yet, and there is still no confirmed start date for its subsidised listing. Current information only indicates that it is expected to be added “soon”, but with timing dependent on ongoing price negotiations between the federal government and Novo Nordisk.

Where things stand now

• The Pharmaceutical Benefits Advisory Committee (PBAC) has recommended that Wegovy be listed on the PBS for people with severe obesity and established cardiovascular disease (for example, after a heart attack or stroke, with BMI ≥ 35).

• Health Minister Mark Butler has publicly committed to working with the manufacturer, Novo Nordisk, to get Wegovy onto the PBS following this recommendation.

• Wegovy is already available in Australia as a private (non‑PBS) prescription, but patients currently pay full price, which can run to several thousand dollars per year.

When might it be listed?

• Multiple reports from early January 2026 state clearly that there is no confirmed PBS listing date yet for Wegovy.

• Government statements say the listing will proceed “soon”, but the actual start date depends on finalising PBS price negotiations with Novo Nordisk and completing the formal listing process.

In practical terms, the most up‑to‑date answer is: Wegovy is expected to be listed on the PBS in Australia in the near future, but there is no official date announced yet , so anyone interested should watch for updates from the Australian Department of Health, PBS schedule announcements, or their GP.

Information gathered from public forums or data available on the internet and portrayed here.